BioTissue
Developer of regenerative medicine implants and an autologous cell-therapy platform focused on orthobiology. The organisation develops biocompatible, form-stable, resorbable 3D scaffold technologies and GMP cell-culture processes to support cartilage, bone and soft-tissue regeneration via minimally invasive surgical implantation and autologous cell grafts.
Industries
Nr. of Employees
small (1-50)
Patents
Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
US-12551510-B2
View Details
Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
US-12551510-B2
View DetailsProducts
Resorbable synthetic 3D scaffold for cartilage repair
A mechanically stable, fully synthetic, cell-free three-dimensional scaffold intended to be implanted after bone-marrow stimulation to retain endogenous stem cells and support hyaline-like cartilage regeneration. Designed for minimally invasive implantation and complete resorption within months.
Autologous cell-seeded 3D tissue grafts (cell therapy platform)
Tissue-engineered autologous implants produced by isolating and expanding patient cells in a GMP environment, then seeding them into a porous, form-stable matrix to generate living transplants for cartilage, bone, oral bone, mucosa and skin defects.
chondrotissue®
A biologically compatible, tissue-conserving and completely absorbable implant applied to cartilage defects to integrate with surrounding tissue, accommodate migrating mesenchymal stem and progenitor cells, and promote the formation of hyaline-like cartilage.
Resorbable synthetic 3D scaffold for cartilage repair
A mechanically stable, fully synthetic, cell-free three-dimensional scaffold intended to be implanted after bone-marrow stimulation to retain endogenous stem cells and support hyaline-like cartilage regeneration. Designed for minimally invasive implantation and complete resorption within months.
Autologous cell-seeded 3D tissue grafts (cell therapy platform)
Tissue-engineered autologous implants produced by isolating and expanding patient cells in a GMP environment, then seeding them into a porous, form-stable matrix to generate living transplants for cartilage, bone, oral bone, mucosa and skin defects.
chondrotissue®
A biologically compatible, tissue-conserving and completely absorbable implant applied to cartilage defects to integrate with surrounding tissue, accommodate migrating mesenchymal stem and progenitor cells, and promote the formation of hyaline-like cartilage.
Services
GMP laboratory expansion and seeding of patient-derived cells into three-dimensional matrices for production and supply of autologous tissue grafts to surgical centres.
GMP laboratory expansion and seeding of patient-derived cells into three-dimensional matrices for production and supply of autologous tissue grafts to surgical centres.
Expertise Areas
- Tissue engineering
- Orthobiology
- Autologous cell therapy manufacturing
- Resorbable scaffold biomaterials
Key Technologies
- 3D biocompatible scaffold technology
- Resorbable synthetic polymer scaffolds
- Autologous cell isolation and expansion (GMP)
- Cell seeding into porous matrices
News & Updates
Clinical follow-up data reported for autologous cell-seeded cartilage grafts with up to 12 years of follow-up.
Clinical follow-up data reported for autologous cell-seeded cartilage grafts with up to 12 years of follow-up.